Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults

Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Lin Yuan, Yi-Jiao Huang, Yan Zheng, Jingjing Chen, Bo Ying, Zuoyun Xiang, Jin Shi, Jincun Zhao, Zhen Huang, View ORCID ProfileCheng-Feng Qin
doi: https://doi.org/10.1101/2022.05.30.22275753
Xiaoqiang Liu
1Yunnan Province Centre for Disease Control and Prevention, Kunming, Yunnan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhua Li
2National Institutes for Food and Drug Control, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhongfang Wang
3Respiratory Medicine, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shouchun Cao
2National Institutes for Food and Drug Control, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weijin Huang
2National Institutes for Food and Drug Control, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Yuan
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi-Jiao Huang
5State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Zheng
1Yunnan Province Centre for Disease Control and Prevention, Kunming, Yunnan, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingjing Chen
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Ying
6Suzhou Abogen Biosciences Co., Ltd., Suzhou, Jiangsu, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zuoyun Xiang
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin Shi
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jincun Zhao
3Respiratory Medicine, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: qincf{at}bmi.ac.cn hz{at}walvax.com zhaojincun{at}gird.cn
Zhen Huang
4Walvax Biotechnology Co., Ltd., Kunming, Yunnan China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: qincf{at}bmi.ac.cn hz{at}walvax.com zhaojincun{at}gird.cn
Cheng-Feng Qin
5State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China
7Research Unit of Discovery and Tracing of Natural Focus Diseases, Chinese Academy of Medical Sciences, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cheng-Feng Qin
  • For correspondence: qincf{at}bmi.ac.cn hz{at}walvax.com zhaojincun{at}gird.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
PreviousNext
Posted May 31, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Lin Yuan, Yi-Jiao Huang, Yan Zheng, Jingjing Chen, Bo Ying, Zuoyun Xiang, Jin Shi, Jincun Zhao, Zhen Huang, Cheng-Feng Qin
medRxiv 2022.05.30.22275753; doi: https://doi.org/10.1101/2022.05.30.22275753
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Lin Yuan, Yi-Jiao Huang, Yan Zheng, Jingjing Chen, Bo Ying, Zuoyun Xiang, Jin Shi, Jincun Zhao, Zhen Huang, Cheng-Feng Qin
medRxiv 2022.05.30.22275753; doi: https://doi.org/10.1101/2022.05.30.22275753

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)